• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量磁化率映射作为帕金森病伴痴呆患者皮质下和边缘铁异常的指标。

Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.

机构信息

Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong.

Philips Healthcare, Hong Kong.

出版信息

Neuroimage Clin. 2018 Jul 27;20:365-373. doi: 10.1016/j.nicl.2018.07.028. eCollection 2018.

DOI:10.1016/j.nicl.2018.07.028
PMID:30128274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6096006/
Abstract

Late stage Parkinson's disease (PD) patients were commonly observed with other non-motor comorbidities such as dementia and psychosis. While abnormal iron level in the substantia nigra was clinically accepted as a biomarker of PD, it was also suggested that the increased iron deposition could impair other brain regions and induce non-motor symptoms. A new Magnetic Resonance Imaging (MRI) called Quantitative Susceptibility Mapping (QSM) has been found to measure iron concentration in the grey matter reliably. In this study, we investigated iron level of different subcortical and limbic structures of Parkinson's disease (PD) patients with and without dementia by QSM. QSM and volumetric analysis by MRI were performed in 10 PD dementia (PDD) patients (73 ± 6 years), 31 PD patients (63 ± 8 years) and 27 healthy controls (62 ± 7 years). No significant differences were observed in the L-Dopa equivalent dosage for the two PD groups (p = 0.125). Putative iron content was evaluated in different subcortical and limbic structures of the three groups, as well as its relationship with cognitive performance. One-way ANCOVA with FDR adjustment at level of 0.05, adjusted for age and gender, showed significant group differences for left and right hippocampus (p = 0.015 & 0.032, respectively, BH-corrected for multiple ROIs) and right thalamus (p = 0.032, BH-corrected). Post-hoc test with Bonferroni's correction suggested higher magnetic susceptibility in PDD patients than healthy controls in the left and right hippocampus (p = 0.001 & 0.047, respectively, Bonferroni's corrected), while PD patients had higher magnetic susceptibility than the healthy controls in right hippocampus and right thalamus (p = 0.006 & 0.005, respectively, Bonferroni's corrected). PDD patients also had higher susceptibility than the non-demented PD patients in left hippocampus (p = 0.046, Bonferroni's corrected). The magnetic susceptibilities of the left and right hippocampus were negatively correlated with the Mini-Mental State Examination score ( = -0.329 & -0.386, respectively; p < 0.05). This study provides support for iron accumulation in limbic structures of PDD and PD patients and its correlation with cognitive performance, however, its putative involvement in development of non-motor cognitive dysfunction in PD pathogenesis remains to be elucidated.

摘要

晚期帕金森病 (PD) 患者常伴有其他非运动性共病,如痴呆和精神病。虽然黑质中的铁异常水平被临床认为是 PD 的生物标志物,但也有研究表明,铁沉积增加会损害其他脑区并引起非运动症状。一种新的磁共振成像 (MRI) 技术,定量磁化率映射 (QSM),已被发现可可靠地测量灰质中的铁浓度。在这项研究中,我们通过 QSM 研究了伴有和不伴有痴呆的帕金森病 (PD) 患者的不同皮质下和边缘结构的铁水平。在 10 名帕金森病痴呆 (PDD) 患者 (73 ± 6 岁)、31 名帕金森病患者 (63 ± 8 岁) 和 27 名健康对照者 (62 ± 7 岁) 中进行了 QSM 和 MRI 容积分析。两组 PD 患者的左旋多巴等效剂量无显著差异 (p = 0.125)。在三组不同的皮质下和边缘结构中评估了潜在的铁含量,并评估了其与认知表现的关系。采用 FDR 调整的单因素方差分析,调整年龄和性别,左、右海马体差异有统计学意义 (p = 0.015 和 0.032,BH 校正多个 ROI) 和右丘脑 (p = 0.032,BH 校正)。Bonferroni 校正后的后验检验提示 PDD 患者的左、右海马体的磁化率高于健康对照组 (p = 0.001 和 0.047,Bonferroni 校正),而 PD 患者的右海马体和右丘脑的磁化率高于健康对照组 (p = 0.006 和 0.005,Bonferroni 校正)。PDD 患者的左海马体磁化率也高于非痴呆 PD 患者 (p = 0.046,Bonferroni 校正)。左、右海马体的磁化率与简易精神状态检查评分呈负相关 ( = -0.329 和 -0.386,分别;p < 0.05)。这项研究为 PDD 和 PD 患者边缘结构的铁积累及其与认知表现的相关性提供了支持,然而,其在 PD 发病机制中非运动性认知功能障碍发展中的潜在作用仍有待阐明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/2e1521047042/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/67503b9cea45/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/a3f27794034f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/bec5992bba80/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/346862d67824/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/2e1521047042/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/67503b9cea45/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/a3f27794034f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/bec5992bba80/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/346862d67824/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc61/6096006/2e1521047042/gr5.jpg

相似文献

1
Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.定量磁化率映射作为帕金森病伴痴呆患者皮质下和边缘铁异常的指标。
Neuroimage Clin. 2018 Jul 27;20:365-373. doi: 10.1016/j.nicl.2018.07.028. eCollection 2018.
2
MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.基于 MRI 的脑铁、灰质体积与痴呆和帕金森病风险的相关性:英国生物库队列的观察性和遗传分析。
Neurobiol Dis. 2024 Jul;197:106539. doi: 10.1016/j.nbd.2024.106539. Epub 2024 May 22.
3
Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.采用定量磁化率映射技术对帕金森病患者黑质内铁沉积进行定量分析。
J Neurol Sci. 2018 Mar 15;386:46-52. doi: 10.1016/j.jns.2018.01.008. Epub 2018 Jan 12.
4
Quantitative Susceptibility Mapping in Parkinson's Disease.帕金森病中的定量磁化率成像
PLoS One. 2016 Sep 6;11(9):e0162460. doi: 10.1371/journal.pone.0162460. eCollection 2016.
5
Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.通过定量磁化率成像测量帕金森病中铁的区域渐进性积累。
NMR Biomed. 2017 Apr;30(4). doi: 10.1002/nbm.3489. Epub 2016 Feb 8.
6
Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis.基于磁共振定量磁敏感成像的体素和影像组学分析评估帕金森病患者轻度认知障碍。
Eur Neurol. 2022;85(4):280-290. doi: 10.1159/000522329. Epub 2022 Mar 21.
7
Brain iron deposition is linked with cognitive severity in Parkinson's disease.脑铁沉积与帕金森病认知严重程度相关。
J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):418-425. doi: 10.1136/jnnp-2019-322042. Epub 2020 Feb 20.
8
Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.帕金森病患者脑铁-氧代谢的时空模式。
Eur Radiol. 2024 May;34(5):3074-3083. doi: 10.1007/s00330-023-10283-1. Epub 2023 Oct 19.
9
Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.未经药物治疗的早期帕金森病患者的基底节外铁含量与非运动症状。
Neurol Sci. 2021 Dec;42(12):5297-5304. doi: 10.1007/s10072-021-05223-0. Epub 2021 Apr 16.
10
Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.通过定量磁化率成像测量早期特发性帕金森病中特定区域铁分布紊乱情况
Hum Brain Mapp. 2015 Nov;36(11):4407-20. doi: 10.1002/hbm.22928. Epub 2015 Aug 7.

引用本文的文献

1
Integrated evaluation of Nigrosome 1 sign, neuromelanin-sensitive MR and iron deposition.黑质小体1征、神经黑色素敏感磁共振成像与铁沉积的综合评估
Jpn J Radiol. 2025 Aug 18. doi: 10.1007/s11604-025-01858-7.
2
Quantitative susceptibility mapping study of deep gray matter iron content in glioma patients.胶质瘤患者深部灰质铁含量的定量磁化率图谱研究
Quant Imaging Med Surg. 2025 May 1;15(5):4655-4668. doi: 10.21037/qims-2024-2704. Epub 2025 Apr 28.
3
Perturbations in levels of essential metals less severe in Parkinson's disease without dementia than in Parkinson's disease dementia.

本文引用的文献

1
Cognitive decline in Parkinson disease.帕金森病患者的认知能力下降。
Nat Rev Neurol. 2017 Apr;13(4):217-231. doi: 10.1038/nrneurol.2017.27. Epub 2017 Mar 3.
2
The whole-brain pattern of magnetic susceptibility perturbations in Parkinson's disease.帕金森病的全脑磁化率扰动模式。
Brain. 2017 Jan;140(1):118-131. doi: 10.1093/brain/aww278. Epub 2016 Nov 11.
3
Quantitative Susceptibility Mapping in Parkinson's Disease.帕金森病中的定量磁化率成像
与帕金森病痴呆相比,无痴呆的帕金森病患者体内必需金属水平的扰动较轻。
Metallomics. 2025 Mar 7;17(3). doi: 10.1093/mtomcs/mfaf006.
4
Utilizing combined quantitative multiparametric MRI as potential biomarkers for improved early-stage parkinson's disease diagnosis.利用联合定量多参数磁共振成像作为潜在生物标志物以改善早期帕金森病诊断。
Neurol Sci. 2025 May;46(5):2103-2113. doi: 10.1007/s10072-024-07956-0. Epub 2024 Dec 26.
5
Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies.帕金森病皮层下核团铁沉积:基于定量铁敏感磁共振成像研究的荟萃分析
Chin Med J (Engl). 2025 Mar 20;138(6):678-692. doi: 10.1097/CM9.0000000000003167. Epub 2024 May 28.
6
Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases.铁死亡在神经退行性疾病发病机制及治疗中的研究进展
Front Cell Neurosci. 2024 Mar 7;18:1359453. doi: 10.3389/fncel.2024.1359453. eCollection 2024.
7
Iron Deposition in Parkinson's Disease: A Mini-Review.帕金森病中的铁沉积:小型综述。
Cell Mol Neurobiol. 2024 Feb 23;44(1):26. doi: 10.1007/s10571-024-01459-4.
8
Glutathione Depletion and Concomitant Elevation of Susceptibility in Patients with Parkinson's Disease: State-of-the-Art MR Spectroscopy and Neuropsychological Study.帕金森病患者谷胱甘肽耗竭及易感性升高:最新磁共振波谱和神经心理学研究。
ACS Chem Neurosci. 2023 Dec 20;14(24):4383-4394. doi: 10.1021/acschemneuro.3c00717. Epub 2023 Dec 5.
9
Biomarkers of Parkinson's Disease: From Basic Research to Clinical Practice.帕金森病的生物标志物:从基础研究到临床实践。
Aging Dis. 2024 Aug 1;15(4):1813-1830. doi: 10.14336/AD.2023.1005.
10
Comparison between Dual-Energy CT and Quantitative Susceptibility Mapping in Assessing Brain Iron Deposition in Parkinson Disease.双能 CT 与定量磁化率映射在帕金森病脑铁沉积评估中的比较。
AJNR Am J Neuroradiol. 2023 Apr;44(4):410-416. doi: 10.3174/ajnr.A7822. Epub 2023 Mar 23.
PLoS One. 2016 Sep 6;11(9):e0162460. doi: 10.1371/journal.pone.0162460. eCollection 2016.
4
The Alterations of Cortical Volume, Thickness, Surface, and Density in the Intermediate Sporadic Parkinson's Disease from the Han Population of Mainland China.中国大陆汉族散发性帕金森病中期皮质体积、厚度、表面积及密度的改变
Front Aging Neurosci. 2016 Aug 3;8:185. doi: 10.3389/fnagi.2016.00185. eCollection 2016.
5
Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.载脂蛋白Eε4不影响帕金森病患者的认知表现。
Parkinsonism Relat Disord. 2016 Aug;29:112-6. doi: 10.1016/j.parkreldis.2016.04.013. Epub 2016 Apr 19.
6
Outcome measures for Parkinson's disease dementia: a systematic review.帕金森病痴呆的结局指标:一项系统综述
Mov Disord Clin Pract. 2016 Jan-Feb;3(1):9-18. doi: 10.1002/mdc3.12225. Epub 2015 Sep 16.
7
Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease.皮质厚度、表面积和皮质下体积对帕金森病认知异质性的贡献各不相同。
PLoS One. 2016 Feb 26;11(2):e0148852. doi: 10.1371/journal.pone.0148852. eCollection 2016.
8
In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan.成年期全脑铁沉积的体内磁共振成像图谱
J Neurosci. 2016 Jan 13;36(2):364-74. doi: 10.1523/JNEUROSCI.1907-15.2016.
9
Parkinson's disease dementia: Diagnostic criteria and risk factor review.帕金森病痴呆:诊断标准与风险因素综述
J Clin Exp Neuropsychol. 2015;37(9):988-93. doi: 10.1080/13803395.2015.1073227.
10
Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.考虑临床表型和运动偏侧性的新发帕金森病和轻度认知障碍患者的皮质厚度。
Eur J Neurol. 2015 Dec;22(12):1564-72. doi: 10.1111/ene.12785. Epub 2015 Jul 24.